Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Increased FDG uptake on late-treatment PET in non-tumour-affected oesophagus is prognostic for pathological complete response and disease recurrence in patients undergoing neoadjuvant radiochemotherapy.
Zschaeck S, Hofheinz F, Zöphel K, Bütof R, Jentsch C, Schmollack J, Löck S, Kotzerke J, Baretton G, Weitz J, Baumann M, Krause M. Zschaeck S, et al. Among authors: jentsch c. Eur J Nucl Med Mol Imaging. 2017 Oct;44(11):1813-1822. doi: 10.1007/s00259-017-3742-0. Epub 2017 Jun 9. Eur J Nucl Med Mol Imaging. 2017. PMID: 28600646
Photon vs. proton radiochemotherapy: Effects on brain tissue volume and perfusion.
Petr J, Platzek I, Hofheinz F, Mutsaerts HJMM, Asllani I, van Osch MJP, Seidlitz A, Krukowski P, Gommlich A, Beuthien-Baumann B, Jentsch C, Maus J, Troost EGC, Baumann M, Krause M, van den Hoff J. Petr J, et al. Among authors: jentsch c. Radiother Oncol. 2018 Jul;128(1):121-127. doi: 10.1016/j.radonc.2017.11.033. Epub 2018 Jan 19. Radiother Oncol. 2018. PMID: 29370984
Evaluation of response using FDG-PET/CT and diffusion weighted MRI after radiochemotherapy of pancreatic cancer: a non-randomized, monocentric phase II clinical trial-PaCa-DD-041 (Eudra-CT 2009-011968-11).
Zimmermann C, Distler M, Jentsch C, Blum S, Folprecht G, Zöphel K, Polster H, Troost EGC, Abolmaali N, Weitz J, Baumann M, Saeger HD, Grützmann R. Zimmermann C, et al. Among authors: jentsch c. Strahlenther Onkol. 2021 Jan;197(1):19-26. doi: 10.1007/s00066-020-01654-4. Epub 2020 Jul 7. Strahlenther Onkol. 2021. PMID: 32638040 Free PMC article. Clinical Trial.
Dose dependent cerebellar atrophy in glioma patients after radio(chemo)therapy.
Raschke F, Seidlitz A, Wesemann T, Löck S, Jentsch C, Platzek I, Petr J, van den Hoff J, Kotzerke J, Beuthien-Baumann B, Baumann M, Linn J, Krause M, Troost EGC. Raschke F, et al. Among authors: jentsch c. Radiother Oncol. 2020 Sep;150:262-267. doi: 10.1016/j.radonc.2020.07.044. Epub 2020 Jul 31. Radiother Oncol. 2020. PMID: 32739316
Final Results of the Prospective Biomarker Trial PETra: [11C]-MET-Accumulation in Postoperative PET/MRI Predicts Outcome after Radiochemotherapy in Glioblastoma.
Seidlitz A, Beuthien-Baumann B, Löck S, Jentsch C, Platzek I, Zöphel K, Linge A, Kotzerke J, Petr J, van den Hoff J, Steinbach J, Krex D, Schmitz-Schackert G, Falk M, Baumann M, Krause M. Seidlitz A, et al. Among authors: jentsch c. Clin Cancer Res. 2021 Mar 1;27(5):1351-1360. doi: 10.1158/1078-0432.CCR-20-1775. Epub 2020 Dec 29. Clin Cancer Res. 2021. PMID: 33376095
Value of functional in-vivo endpoints in preclinical radiation research.
Kummer B, Löck S, Gurtner K, Hermann N, Yaromina A, Eicheler W, Baumann M, Krause M, Jentsch C. Kummer B, et al. Among authors: jentsch c. Radiother Oncol. 2021 May;158:155-161. doi: 10.1016/j.radonc.2021.02.024. Epub 2021 Feb 24. Radiother Oncol. 2021. PMID: 33639191 Free article.
26 results